Physician

Cole Robert Kreofsky, M.D.

According to 2025 Medicare claims, Cole Kreofsky, M.D. (NPI: 1497021158) practices radiation oncology in the Bismarck, ND market, with the plurality of this provider's patient population coming from Burleigh, ND. This provider's primary affiliated billing organization is BISMARCK CANCER CENTER (NPI: 1538212162; TIN: 450454363) and primary practice location at 58501-4445. Kreofsky is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), The Rural Advantage LLC (ACO ID: A5257), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kreofsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 361 traditional Medicare patients, billed 6,836 HCPCS/CPT codes, and received $1,083,289 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 376 prescription claims across 114 beneficiaries totaling $5,833 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). DME data shows 12 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,408 to $1,083,289. Similarly, Part D prescription costs have risen steadily, from $501 to $5,833. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	34	66	$4,408
2016	57	125	$13,474
2017	346	3,050	$581,083
2018	449	7,727	$1,384,283
2019	416	8,689	$1,360,589
2020	348	6,300	$1,019,191
2021	290	5,435	$962,418
2022	354	6,052	$1,149,191
2023	358	6,157	$994,661
2024	361	6,836	$1,083,289

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	25	33	$501
2016	29	51	$1,228
2017	32	65	$1,721
2018	79	195	$4,449
2019	94	273	$6,043
2020	94	232	$5,027
2021	67	158	$2,740
2022	103	270	$4,980
2023	101	301	$4,960
2024	114	376	$5,833

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$3,067

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	124	1,235	$300
77427	Radiation treatment management, 5 treatment sessions	103	322	$157
77014	Ct guidance for insertion of radiation therapy fields	147	1,332	$98
77336	Continuing radiation therapy consultation per week	120	337	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	106	126	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	126	7,371	$1,349
Sucralfate	Sucralfate	12	77	$1,126
Oxybutynin Chloride Er	Oxybutynin Chloride	13	972	$325
Megestrol Acetate	Megestrol Acetate	13	420	$199
Hydrocortisone	Hydrocortisone	26	443	$154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$3,067

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Cole Robert Kreofsky, M.D.?

Tedicare shows public-source Medicare data for Cole Robert Kreofsky, M.D. (NPI 1497021158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cole Robert Kreofsky, M.D. have ACO affiliation data?

Cole Robert Kreofsky, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), The Rural Advantage LLC (MSSP, ACO ID A5257), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Cole Robert Kreofsky, M.D.?

Cole Robert Kreofsky, M.D. is linked to BISMARCK CANCER CENTER (billing NPI 1538212162) in the available physician profile data.

Does Cole Robert Kreofsky, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.